Evidence map›Paper›PMID 42010080›Full record

SynthesisDoklady. Biochemistry and biophysics2026

Polymorphism of hOGG1 Gene and Susceptibility to Malignant Neoplasms in People Affected by Long-Term Low-Dose-Rate Exposure.

M A Yanishevskaya, E A Blinova, E A Shishkina, A V Akleyev

Abstract readMeta-Analysis
PubMed Publisher
In one paragraph

Synthesis in Doklady. Biochemistry and biophysics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

M A YanishevskayaSouthern Urals Federal Research and Clinical Center for Medical Biophysics of the Federal Medical Biological Agency, Chelyabinsk, Russia. yanishevskaya@urcrm.ru.
E A BlinovaSouthern Urals Federal Research and Clinical Center for Medical Biophysics of the Federal Medical Biological Agency, Chelyabinsk, Russia.
E A ShishkinaSouthern Urals Federal Research and Clinical Center for Medical Biophysics of the Federal Medical Biological Agency, Chelyabinsk, Russia.
A V AkleyevSouthern Urals Federal Research and Clinical Center for Medical Biophysics of the Federal Medical Biological Agency, Chelyabinsk, Russia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In the previous study [1], we showed an increased risk of malignant neoplasms in carriers of the minor allele rs1052133*G of the hOGG1 gene who were affected by chronic radiation exposure at a wide range of doses (up to 3507 mGy to the red bone marrow at the Techa River (Southern Urals). The objective of the present study was to assess the contribution of radiation factor to the risk of malignant neoplasm development in persons chronically exposed at the Techa River. For this purpose, we analyzed the background level of genetically determined risk in the general population of unexposed people on the basis of meta-analysis of the world literature data on the search for the association of rs1052133 of the hOGG1 gene with the risk of malignant neoplasm development. At the final stage, the results of the meta-analysis were compared with data on exposed people. The study found that unexposed and exposed carriers of the rs1052133*G allele had a comparable increased risk of developing malignant neoplasms, odds ratio OR = 1.20; 95% confidence interval [1.06-1.35], p = 0.01 and odds ratio OR = 1.38; 95% confidence interval [1.05-1.83], p = 0.023, respectively.

Indexed as

DNA GlycosylasesGenetic Predisposition to DiseaseNeoplasms, Radiation-InducedPolymorphism, Single NucleotideRadiation ExposureHumansDNA Glycosylasesoxoguanine glycosylase 1, humanbackground level, genetically determined risk, polymorphismshOGG1ionizing radiationmalignant neoplasmsMeta-analysisrs1052133Ser326CysSouthern UralsTecha river

Identifiers

PMID42010080

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.